Press Releases

OCON Therapeutics, a World Economic Forum Technology Pioneer at the forefront of revolutionizing drug delivery, today announced the successful completion of a $10 million investment round led by RH Capital. This funding will enhance OCON’s ability to provide groundbreaking solutions for treating prevalent uterine pathologies, reinforcing its vision to establish a safer standard of care through its proprietary 3D drug delivery system.